Download Faster and better pandemic response: production of #influenza virus-like particles (VLP) vaccines using plants

Discover more aboue the production of VLP vaccines using plants from Frederic Ors, Vice President, Business Development, Medicago, Canada.

Mr Ors has more than ten years of experience in Licensing, Intellectual Property and busienss development in biotechnology. He joined Medicago in 2001 and oversees Business Development activities. He is also responsible for securing Medicago’s Freedom to Operate and establishing IP strategies. Before joining Medicago, He was licensing manager for four years at one of the largest science and medical universities in France. He has a B.Sc. degree in Biology and a Master degree in Management from Angers University (France), as well as a Diploma in Biomedical business development from Pierre et Marie Curie University (France).

Mr Ors presented on the following topics at the World Influenza Congress Asia Summit 2011

1. Introducing the features and leveraging on the advantages of the manufacturing technology
2. Showcasing pandemic VLP vaccines: Analyzing clinical phase results for H5N1 strains and 2009 H1N1 strain
3. Developing the most optimal international business strategy to maximise market share for VLP vaccines

To learn more, click here to download the slides now!

Join us at World Vaccine Congress Asia 2012 to gain valuable insights from more than 100 experts. Contact us now for more details!

Comments 1

Leave a Reply

Your email address will not be published. Required fields are marked *